Cipla gets USFDA nod for pulmonary arterial hypertension drug - e NEWS

e NEWS

LATEST NEWS

Breaking

Home Top Ad

Ads Here

Tuesday, April 30, 2019

Cipla gets USFDA nod for pulmonary arterial hypertension drug

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Ambrisentan tablets,

from Business Line - Home http://bit.ly/2ZJeMiJ
via IFTTT

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages